Experts Find 3 Things That Can Protect The Brain From Alzheimer's Disease, National Academies of Sciences, Engineering, and Medicine Study Reveals
GlaxoSmithKline (GSK): 3 Reasons You Should Be Concerned
This Cornell University Scientist Saved An $11-Million Industry—And Ignited The GMO Wars
The FDA Has Never Approved A Drug Like This In Its 111-Year History
How To Train Your Drugs: From Nanotherapeutics To Nanobots
As Fitbit (FIT) Rebuilds, Competition Will Only Get Tougher
Freezing Frenzy: Cryotherapy Makes Big Promises Despite Dearth Of Evidence
The One Medical Device Stock That Could be a Life-Changer
What You Need To Know About AbbVie (ABBV)'s Much-Anticipated Follow Up To Humira
3 Biotechs For The Adventurous Investor
Chinese Courts Call For Death Penalty For Researchers Who Commit Fraud
If Esperion (ESPR) Wants To Market The Next Big Cholesterol Drug, It Will Take Strategy
Mylan (MYL) Shareholders Balk at Executive Pay Package But Re-Elects Board Despite EpiPen Scandal
New GlaxoSmithKline (GSK) CEO Looks To Unload Sports Nutrition Brand Successor Bought For $205 Million
Teva (TEVA) Ordered To Pay GlaxoSmithKline (GSK) $235 Million In Coreg Patent Row
Plant Problems Lead The FDA To Reject Pfizer (PFE)'s Epogen Biosimilar Again
A Startup Founded By SolarCity And Google (GOOG) Alums Wants To Tell You Your 'Fertility Age'—Here's What That Means
Tiny Nanoparticles Offer Significant Potential In Detecting/Treating Disease New Review Of Work On Exosomes, Trends in Molecular Medicine Reveals
See All News >